오르가노제네시스 홀딩스 주식회사
DE ˙ DB ˙ US68621F1021
€1.99 ↓ -0.09 (-4.33%)
2026-06-05
주가
SecurityDE:2PQ / Organogenesis Holdings Inc.
InstitutionCapital Square, LLC
Latest Disclosed Ownership19,113 shares
Latest Disclosed Value $ 44,915
Capital Square, LLC reports 76.84% increase in ownership of 2PQ / Organogenesis Holdings Inc.

On May 11, 2026 - Capital Square, LLC filed a 13F-HR form disclosing ownership of 19,113 shares of Organogenesis Holdings Inc. (DE:2PQ) valued at $38,991 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,808 shares of Organogenesis Holdings Inc.. This represents a change in shares of 76.84% during the quarter. The current value of the position is $38,035 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 19,113 8,305 76.84 45 -20.00 0.0207
2026-02-13 2025-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 10,808 -6,202 -36.46 56 -22.54 0.0286
2025-11-21 2025-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 17,010 -5,490 -24.40 72 -26.04 0.0366
2025-08-11 2025-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 22,500 -600 -2.60 97 -3.03 0.0516
2025-05-14 2025-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 23,100 500 2.21 100 23.75 0.0586
2025-02-13 2024-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 22,600 2,000 9.71 80 37.93 0.0457
2024-11-13 2024-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 20,600 300 1.48 59 -4.92 0.0358
2024-08-01 2024-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 20,300 50 0.25 61 7.02 0.0399
2024-05-07 2024-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 20,250 -200 -0.98 58 -31.33 0.0406
2024-01-26 2023-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 20,450 3,930 23.79 84 118.42 0.0945
2023-11-13 2023-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 16,520 16,520 39 0.0523
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.